You may qualify to participate if you:
- Are 18 (or age of majority) to 65 years old
- Have been diagnosed with moderate-to-severe RA in the last 2 years
- Are currently taking an RA medication called methotrexate
There may be other requirements to participate.
If you qualify and enroll you will receive:
- The opportunity to potentially help advance medical knowledge about RA and improve patient care
- The oral investigational drug and study-related assessments at no cost*
- Study-related monitoring by a RA study team
* Qualified patients may receive, at no cost, study-required medical care, research medication, laboratory work, and evaluations. Patients or their insurance may be responsible for standard-of-care procedures, scans, hospital & doctor visits, and other medications to treat their disease.
You won’t be asked for any personal information until after you have completed the questionnaire and decide to proceed. Your information will only be used for the purpose of this study.
The research study has 4 phases: Screening, Treatment A, Treatment B, and Follow-up. There are about 11 visits over approximately 32 weeks. If you meet the criteria for the study, you will be assigned by chance to receive either the oral investigational drug or the placebo during the first 12 weeks of treatment. During the second 12 weeks, all participants will receive an approved drug for RA.
